Literature DB >> 26223634

Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.

Justine E Sunshine1, Brendan B Larsen2, Brandon Maust2, Ellie Casey2, Wenje Deng2, Lennie Chen2, Dylan H Westfall2, Moon Kim2, Hong Zhao2, Suvankar Ghorai2, Erinn Lanxon-Cookson2, Morgane Rolland3, Ann C Collier4, Janine Maenza4, James I Mullins5, Nicole Frahm6.   

Abstract

UNLABELLED: To understand the interplay between host cytotoxic T-lymphocyte (CTL) responses and the mechanisms by which HIV-1 evades them, we studied viral evolutionary patterns associated with host CTL responses in six linked transmission pairs. HIV-1 sequences corresponding to full-length p17 and p24 gag were generated by 454 pyrosequencing for all pairs near the time of transmission, and seroconverting partners were followed for a median of 847 days postinfection. T-cell responses were screened by gamma interferon/interleukin-2 (IFN-γ/IL-2) FluoroSpot using autologous peptide sets reflecting any Gag variant present in at least 5% of sequence reads in the individual's viral population. While we found little evidence for the occurrence of CTL reversions, CTL escape processes were found to be highly dynamic, with multiple epitope variants emerging simultaneously. We found a correlation between epitope entropy and the number of epitope variants per response (r = 0.43; P = 0.05). In cases in which multiple escape mutations developed within a targeted epitope, a variant with no fitness cost became fixed in the viral population. When multiple mutations within an epitope achieved fitness-balanced escape, these escape mutants were each maintained in the viral population. Additional mutations found to confer escape but undetected in viral populations incurred high fitness costs, suggesting that functional constraints limit the available sites tolerable to escape mutations. These results further our understanding of the impact of CTL escape and reversion from the founder virus in HIV infection and contribute to the identification of immunogenic Gag regions most vulnerable to a targeted T-cell attack. IMPORTANCE: Rapid diversification of the viral population is a hallmark of HIV-1 infection, and understanding the selective forces driving the emergence of viral variants can provide critical insight into the interplay between host immune responses and viral evolution. We used deep sequencing to comprehensively follow viral evolution over time in six linked HIV transmission pairs. We then mapped T-cell responses to explore if mutations arose due to adaption to the host and found that escape processes were often highly dynamic, with multiple mutations arising within targeted epitopes. When we explored the impact of these mutations on replicative capacity, we found that dynamic escape processes only resolve with the selection of mutations that conferred escape with no fitness cost to the virus. These results provide further understanding of the complicated viral-host interactions that occur during early HIV-1 infection and may help inform the design of future vaccine immunogens.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26223634      PMCID: PMC4580195          DOI: 10.1128/JVI.01876-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund; Can Keşmir
Journal:  Immunogenetics       Date:  2005-03-03       Impact factor: 2.846

2.  Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

Authors:  M A Alexander-Miller; G R Leggatt; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

3.  Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays.

Authors:  E L Delwart; H W Sheppard; B D Walker; J Goudsmit; J I Mullins
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load.

Authors:  Nicole Frahm; Sharon Adams; Photini Kiepiela; Caitlyn H Linde; Hannah S Hewitt; Mathias Lichterfeld; Kaori Sango; Nancy V Brown; Eunice Pae; Alysse G Wurcel; Marcus Altfeld; Margaret E Feeney; Todd M Allen; Timothy Roach; M Anne St John; Eric S Daar; Eric Rosenberg; Bette Korber; Francesco Marincola; Bruce D Walker; Philip J R Goulder; Christian Brander
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Clinical and epidemiologic features of primary HIV infection.

Authors:  T Schacker; A C Collier; J Hughes; T Shea; L Corey
Journal:  Ann Intern Med       Date:  1996-08-15       Impact factor: 25.391

6.  Biological and virologic characteristics of primary HIV infection.

Authors:  T W Schacker; J P Hughes; T Shea; R W Coombs; L Corey
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

7.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1.

Authors:  Simon Brackenridge; Edward J Evans; Mireille Toebes; Nilu Goonetilleke; Michael K P Liu; Kati di Gleria; Ton N Schumacher; Simon J Davis; Andrew J McMichael; Geraldine M Gillespie
Journal:  J Virol       Date:  2011-03-23       Impact factor: 5.103

9.  The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.

Authors:  Nilu Goonetilleke; Michael K P Liu; Jesus F Salazar-Gonzalez; Guido Ferrari; Elena Giorgi; Vitaly V Ganusov; Brandon F Keele; Gerald H Learn; Emma L Turnbull; Maria G Salazar; Kent J Weinhold; Stephen Moore; Norman Letvin; Barton F Haynes; Myron S Cohen; Peter Hraber; Tanmoy Bhattacharya; Persephone Borrow; Alan S Perelson; Beatrice H Hahn; George M Shaw; Bette T Korber; Andrew J McMichael
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

10.  Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.

Authors:  Ryan M Troyer; John McNevin; Yi Liu; Shao Chong Zhang; Randall W Krizan; Awet Abraha; Denis M Tebit; Hong Zhao; Santiago Avila; Michael A Lobritz; M Juliana McElrath; Sylvie Le Gall; James I Mullins; Eric J Arts
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more
  17 in total

1.  Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors.

Authors:  Sean C Patro; Leah D Brandt; Michael J Bale; Elias K Halvas; Kevin W Joseph; Wei Shao; Xiaolin Wu; Shuang Guo; Ben Murrell; Ann Wiegand; Jonathan Spindler; Castle Raley; Christopher Hautman; Michele Sobolewski; Christine M Fennessey; Wei-Shau Hu; Brian Luke; Jenna M Hasson; Aurelie Niyongabo; Adam A Capoferri; Brandon F Keele; Jeff Milush; Rebecca Hoh; Steven G Deeks; Frank Maldarelli; Stephen H Hughes; John M Coffin; Jason W Rausch; John W Mellors; Mary F Kearney
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-27       Impact factor: 11.205

2.  Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection.

Authors:  Hongzhao Li; Robert W Omange; Binhua Liang; Nikki Toledo; Yan Hai; Lewis R Liu; Dane Schalk; Jose Crecente-Campo; Tamara G Dacoba; Andrew B Lambe; So-Yon Lim; Lin Li; Mohammad Abul Kashem; Yanmin Wan; Jorge F Correia-Pinto; Michael S Seaman; Xiao Qing Liu; Robert F Balshaw; Qingsheng Li; Nancy Schultz-Darken; Maria J Alonso; Francis A Plummer; James B Whitney; Ma Luo
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

3.  Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection.

Authors:  Korey R Demers; George Makedonas; Marcus Buggert; Michael A Eller; Sarah J Ratcliffe; Nilu Goonetilleke; Chris K Li; Leigh Anne Eller; Kathleen Rono; Lucas Maganga; Sorachai Nitayaphan; Hannah Kibuuka; Jean-Pierre Routy; Mark K Slifka; Barton F Haynes; Andrew J McMichael; Nicole F Bernard; Merlin L Robb; Michael R Betts
Journal:  PLoS Pathog       Date:  2016-08-03       Impact factor: 6.823

4.  Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.

Authors:  Yushen Du; Tian-Hao Zhang; Lei Dai; Xiaojuan Zheng; Aleksandr M Gorin; John Oishi; Ting-Ting Wu; Janice M Yoshizawa; Xinmin Li; Otto O Yang; Otoniel Martinez-Maza; Roger Detels; Ren Sun
Journal:  mBio       Date:  2017-11-28       Impact factor: 7.867

5.  Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.

Authors:  Gustavo H Kijak; Eric Sanders-Buell; Agnes-Laurence Chenine; Michael A Eller; Nilu Goonetilleke; Rasmi Thomas; Sivan Leviyang; Elizabeth A Harbolick; Meera Bose; Phuc Pham; Celina Oropeza; Kultida Poltavee; Anne Marie O'Sullivan; Erik Billings; Melanie Merbah; Margaret C Costanzo; Joanna A Warren; Bonnie Slike; Hui Li; Kristina K Peachman; Will Fischer; Feng Gao; Claudia Cicala; James Arthos; Leigh A Eller; Robert J O'Connell; Samuel Sinei; Lucas Maganga; Hannah Kibuuka; Sorachai Nitayaphan; Mangala Rao; Mary A Marovich; Shelly J Krebs; Morgane Rolland; Bette T Korber; George M Shaw; Nelson L Michael; Merlin L Robb; Sodsai Tovanabutra; Jerome H Kim
Journal:  PLoS Pathog       Date:  2017-07-31       Impact factor: 6.823

6.  Patterns and rates of viral evolution in HIV-1 subtype B infected females and males.

Authors:  Michael J Dapp; Kord M Kober; Lennie Chen; Dylan H Westfall; Kim Wong; Hong Zhao; Breana M Hall; Wenjie Deng; Thomas Sibley; Suvankar Ghorai; Katie Kim; Natalie Chen; Sarah McHugh; Lily Au; Mardge Cohen; Kathryn Anastos; James I Mullins
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

7.  Immune escape mutations in HIV-1 controllers in the Brazilian Amazon region.

Authors:  Samara Tatielle Monteiro Gomes; Ednelza da Silva Graça Amoras; Érica Ribeiro Gomes; Maria Alice Freitas Queiroz; Edivaldo Costa Sousa Júnior; Janaína Mota de Vasconcelos Massafra; Poliana da Silva Lemos; João Lídio Vianez Júnior; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  BMC Infect Dis       Date:  2020-07-25       Impact factor: 3.090

8.  Dual HLA B*42 and B*81-reactive T cell receptors recognize more diverse HIV-1 Gag escape variants.

Authors:  Funsho Ogunshola; Gursev Anmole; Rachel L Miller; Emily Goering; Thandeka Nkosi; Daniel Muema; Jaclyn Mann; Nasreen Ismail; Denis Chopera; Thumbi Ndung'u; Mark A Brockman; Zaza M Ndhlovu
Journal:  Nat Commun       Date:  2018-11-27       Impact factor: 14.919

9.  Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.

Authors:  Hongzhao Li; Yan Hai; So-Yon Lim; Nikki Toledo; Jose Crecente-Campo; Dane Schalk; Lin Li; Robert W Omange; Tamara G Dacoba; Lewis R Liu; Mohammad Abul Kashem; Yanmin Wan; Binhua Liang; Qingsheng Li; Eva Rakasz; Nancy Schultz-Darken; Maria J Alonso; Francis A Plummer; James B Whitney; Ma Luo
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

Review 10.  Prospecting for an HIV vaccine.

Authors:  D M Brett-Major; T A Crowell; N L Michael
Journal:  Trop Dis Travel Med Vaccines       Date:  2017-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.